An unusual cause of fatal rapid-onset ataxia plus syndrome.

Q3 Medicine
Cerebellum and Ataxias Pub Date : 2017-04-21 eCollection Date: 2017-01-01 DOI:10.1186/s40673-017-0063-9
Ivan Kmezic, Jan Weinberg, Dan Hauzenberger, Farouk Hashim, Evangelia Kollia, Monika Klimkowska, Inger Nennesmo, Martin Paucar
{"title":"An unusual cause of fatal rapid-onset ataxia plus syndrome.","authors":"Ivan Kmezic,&nbsp;Jan Weinberg,&nbsp;Dan Hauzenberger,&nbsp;Farouk Hashim,&nbsp;Evangelia Kollia,&nbsp;Monika Klimkowska,&nbsp;Inger Nennesmo,&nbsp;Martin Paucar","doi":"10.1186/s40673-017-0063-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Progressive multifocal leukoencephalopathy (PML) is a demyelinating disorder of the central nervous system caused by reactivation of the JC-virus and is in most cases associated with underlying immunosuppression. Acquired immune deficiency syndrome (AIDS) and hematological malignancies are well-known predisposing factors for PML. However, in the past ten years, various pharmacological agents have been associated with increased risk of PML. Based on the phenomenology PML can be divided into the cerebral form and the rare cerebellar form.</p><p><strong>Case presentation: </strong>Here we describe a man affected by polycythemia vera (PCV) that was treated with hydroxyurea (HU) and developed PML. The initially PML presentation included ataxia as one of the main features. Brain MRI displayed widespread supratentorial and infratentorial lesions. Immunological analysis revealed absence of reactivity to a wide range of antigens. The course of disease was rapidly progressive with fatal outcome - autopsy ruled out leukemic transformation.</p><p><strong>Conclusion: </strong>The occurrence of PML in PCV patients is very rare and has been reported only once. Movement disorders, such as ataxia, are also less frequent. In the present case the PML was likely multifactorial.</p>","PeriodicalId":36752,"journal":{"name":"Cerebellum and Ataxias","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2017-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s40673-017-0063-9","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cerebellum and Ataxias","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40673-017-0063-9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2017/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Progressive multifocal leukoencephalopathy (PML) is a demyelinating disorder of the central nervous system caused by reactivation of the JC-virus and is in most cases associated with underlying immunosuppression. Acquired immune deficiency syndrome (AIDS) and hematological malignancies are well-known predisposing factors for PML. However, in the past ten years, various pharmacological agents have been associated with increased risk of PML. Based on the phenomenology PML can be divided into the cerebral form and the rare cerebellar form.

Case presentation: Here we describe a man affected by polycythemia vera (PCV) that was treated with hydroxyurea (HU) and developed PML. The initially PML presentation included ataxia as one of the main features. Brain MRI displayed widespread supratentorial and infratentorial lesions. Immunological analysis revealed absence of reactivity to a wide range of antigens. The course of disease was rapidly progressive with fatal outcome - autopsy ruled out leukemic transformation.

Conclusion: The occurrence of PML in PCV patients is very rare and has been reported only once. Movement disorders, such as ataxia, are also less frequent. In the present case the PML was likely multifactorial.

Abstract Image

Abstract Image

Abstract Image

致死性快速发作共济失调综合征的不寻常原因。
背景:进行性多灶性脑白质病(PML)是一种由jc病毒再激活引起的中枢神经系统脱髓鞘疾病,在大多数情况下与潜在的免疫抑制有关。众所周知,获得性免疫缺陷综合征(艾滋病)和血液系统恶性肿瘤是PML的易感因素。然而,在过去的十年中,各种药物与PML的风险增加有关。根据现象学,PML可分为脑型和少见的小脑型。病例介绍:在这里,我们描述了一个受真性红细胞增多症(PCV)影响的人,他接受了羟基脲(HU)治疗并发展为PML。最初的PML表现包括共济失调作为主要特征之一。脑MRI显示广泛的幕上和幕下病变。免疫学分析显示对多种抗原缺乏反应性。病情进展迅速,结果致命——尸检排除了白血病转化的可能。结论:PCV患者发生PML非常罕见,仅有一例报道。运动障碍,如共济失调,也不太常见。在本病例中,PML可能是多因素的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cerebellum and Ataxias
Cerebellum and Ataxias Medicine-Neurology (clinical)
自引率
0.00%
发文量
0
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信